Literature DB >> 29632976

Do pulmonary findings of granulomatosis with polyangiitis respond to anti-tuberculosis treatment?

Döndü Üsküdar Cansu1, Nilgün Işıksalan Özbülbül2, Gülsüm Akyol3, Deniz Arık4, Cengiz Korkmaz5.   

Abstract

Granulomatosis with polyangiitis (GPA) involves upper and lower respiratory tracts and kidneys. Lung involvement is among the most important organ involvements in GPA. GPA's lung involvement might be confused with other granulomatous conditions with lung involvement. In this report, we presented clinical features of two cases with GPA who had been diagnosed as tuberculosis (TBC) and well treated with anti-tuberculosis (anti-TBC) drugs. However, one of two cases had ear-nose-throat (ENT) manifestations before the diagnosis of TBC and her extrapulmonary findings related with GPA have added to clinical features in the following years. In the second case, the manifestations of GPA appeared after 13 months of anti-TBC treatment. We speculated that lung involvement in these cases may be due to GPA rather than TBC. Our aim was to highlight difficulties in the differential diagnosis between GPA and TBC and suggest the possible beneficial effect of anti-TBC drugs on the lung involvement due to GPA in light of the literature data.

Entities:  

Keywords:  Anti-tuberculosis treatment; Granulomatosis with polyangiitis; Tuberculosis; Wegener granulomatosis

Mesh:

Substances:

Year:  2018        PMID: 29632976     DOI: 10.1007/s00296-018-4027-z

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  20 in total

1.  Wegener's granulomatosis: an isolated lung mass responding to antituberculosis therapy and atypical course.

Authors:  G C Khilnani; A Banga; S C Sharma; S D Gupta
Journal:  J Assoc Physicians India       Date:  2003-07

2.  Limited Wegener's disease initially misdiagnosed as tuberculosis.

Authors:  F Breuskin; M A Polet; J Dorzee; J Fastrez; P Van Eeckhout; A Henkinbrant; J P d'Odemont
Journal:  Acta Clin Belg       Date:  2003 Jul-Aug       Impact factor: 1.264

3.  Suppression of T-lymphocyte rosettes by rifampin. Studies in normals and patients with tuberculosis.

Authors:  S Gupta; M H Grieco; I Siegel
Journal:  Ann Intern Med       Date:  1975-04       Impact factor: 25.391

4.  Two cases of 'Wegener's tuberculosis'.

Authors:  C Gordon; R Luqmani; P Fields; A J Howie; P Emery
Journal:  Br J Rheumatol       Date:  1993-02

Review 5.  Clinical features of Poncet's disease. From the description of 198 cases found in the literature.

Authors:  Juan C Rueda; Marie-Francoise Crepy; Rubén D Mantilla
Journal:  Clin Rheumatol       Date:  2013-04-28       Impact factor: 2.980

6.  Rifampicin--a mild immunosuppressive agent for psoriasis.

Authors:  Nikolai Tsankov; Ivan Grozdev
Journal:  J Dermatolog Treat       Date:  2010-07-24       Impact factor: 3.359

7.  A diagnostic dilemma: differentiating between granulomatosis with polyangiitis and tuberculosis.

Authors:  Farrouq S Mahmood; Edward Schwatz; Shinoy Kurrup; Charles Sharp; Georgina Hands; Alison Moody
Journal:  Clin Med (Lond)       Date:  2013-08       Impact factor: 2.659

8.  Immunomodulating activity of rifampicin.

Authors:  H M Ziglam; I Daniels; R G Finch
Journal:  J Chemother       Date:  2004-08       Impact factor: 1.714

9.  Cell mediated and humoral immunity and light-chain proteinuria in rifampicin-treated tuberculous patients.

Authors:  S H Galal; S H Khalil; W el Husseiny; J Brock
Journal:  Allerg Immunol (Leipz)       Date:  1988
View more
  1 in total

Review 1.  Challenges in diagnosis of limited granulomatosis with polyangiitis.

Authors:  Olena Zimba; Bohdana Doskaliuk; Roman Yatsyshyn; Mykola Bahrii; Marta Hrytsevych
Journal:  Rheumatol Int       Date:  2021-04-20       Impact factor: 2.631

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.